Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:
Alphatec Holdings, Inc. (NASDAQ:ATEC - Get Rating) Director Elizabeth Ann Altman sold 8,009 shares of the business's stock in a transaction dated Wednesday, August 17th. The shares were sold at an average price of $9.06, for a total transaction of $72,561.54. Following the completion of the sale, the director now directly owns 40,431 shares of the company's stock, valued at approximately $366,304.86. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Alphatec Price Performance
NASDAQ ATEC traded down $0.51 during trading on Wednesday, hitting $8.93. 475,949 shares of the company's stock were exchanged, compared to its average volume of 699,550. The company has a current ratio of 2.19, a quick ratio of 1.34 and a debt-to-equity ratio of 29.74. The company has a market cap of $934.58 million, a PE ratio of -5.51 and a beta of 1.62. Alphatec Holdings, Inc. has a fifty-two week low of $5.73 and a fifty-two week high of $15.31. The stock's 50 day moving average price is $7.34 and its two-hundred day moving average price is $9.26. Institutional Inflows and Outflows
Several institutional investors have recently bought and sold shares of ATEC. Allspring Global Investments Holdings LLC acquired a new position in Alphatec during the fourth quarter worth about $356,000. Advisor Group Holdings Inc. increased its stake in shares of Alphatec by 65.4% in the fourth quarter. Advisor Group Holdings Inc. now owns 35,787 shares of the medical technology company's stock valued at $408,000 after buying an additional 14,153 shares during the period. Envestnet Asset Management Inc. increased its stake in shares of Alphatec by 1,344.0% in the fourth quarter. Envestnet Asset Management Inc. now owns 374,788 shares of the medical technology company's stock valued at $4,284,000 after buying an additional 348,834 shares during the period. Cullen Frost Bankers Inc. increased its stake in shares of Alphatec by 4.5% in the fourth quarter. Cullen Frost Bankers Inc. now owns 55,365 shares of the medical technology company's stock valued at $633,000 after buying an additional 2,385 shares during the period. Finally, ProShare Advisors LLC acquired a new position in shares of Alphatec in the fourth quarter valued at approximately $177,000. Institutional investors and hedge funds own 53.52% of the company's stock. Wall Street Analysts Forecast Growth
A number of brokerages have recently issued reports on ATEC. Lake Street Capital reissued a "buy" rating and issued a $9.00 target price on shares of Alphatec in a research report on Friday, July 15th. HC Wainwright boosted their price target on Alphatec from $19.00 to $20.00 in a research note on Friday, May 6th. The Goldman Sachs Group dropped their price target on Alphatec from $11.00 to $9.50 and set a "neutral" rating for the company in a research note on Monday, August 8th. Finally, Needham & Company LLC dropped their price target on Alphatec from $15.00 to $13.00 and set a "buy" rating for the company in a research note on Thursday, May 26th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and four have assigned a buy rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $15.08.About Alphatec (Get Rating)
Alphatec Holdings, Inc, a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform designed to reduce the risk of intraoperative nerve injury; Sigma transforaminal lumbar interbody fusion pedicle-based access system that provides direct visualization of anatomical landmarks; Sigma PTP Access and Patient Positioning System; squadron lateral retractor designed to maximize patient outcomes; Invictus Spinal Fixation System, a thoracolumbar fixation system to treat a range of pathologies; and Invictus MIS SingleStep System that provides minimally invasive pedicle screw placement.See AlsoGet a free copy of the StockNews.com research report on Alphatec (ATEC)Lowe’s Stands Out Amid Q2 Retail Reports Agilent Technologies Proves Its Worth VS Illumina Target’s Results Cap Upside Potential For Retail Stocks Are These 3 Video Game Stocks Now In Play? 2 Long-Term EV Plays Trading Under $20
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Alphatec, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Alphatec wasn't on the list.
While Alphatec currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Complete the form below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter:
David McNatt discusses ESG investing and offers ways to avoid pitfalls and to understand exactly what kinds of companies you are buying.
Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.
MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.
Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.
Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.
MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.
Twitter Facebook StockTwits Financial Juice YouTube
© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved. 326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257 MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds
© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.